Maharaj, Anil R.
Wu, Huali
Hornik, Christoph P.
Arrieta, Antonio
James, Laura
Bhatt-Mehta, Varsha
Bradley, John
Muller, William J.
Al-Uzri, Amira
Downes, Kevin J.
Cohen-Wolkowiez, Michael
Funding for this research was provided by:
National Institutes of Health (1R01-HD076676-01A1)
Article History
Received: 1 July 2019
Accepted: 27 March 2020
First Online: 22 April 2020
Compliance with ethical standards
:
: M.C.W. receives support for research from the NIH (5R01-HD076676), NIH (HHSN275201000003I), NIAID/NIH (HHSN272201500006I), FDA (1U18-FD006298), the Biomedical Advanced Research and Development Authority (HHSO1201300009C), and from the industry for the drug development in adults and children (ExternalRef removed). C.P.H. receives salary support for research from National Institute for Child Health and Human Development (NICHD) (K23HD090239), the U.S. government for his work in pediatric and neonatal clinical pharmacology (Government Contract HHSN267200700051C, PI: Benjamin, under the Best Pharmaceuticals for Children Act), and industry for drug development in children. KJD has received research support from Merck, Inc. and Pfizer, Inc. and is supported by NICHD K23HD091365.